PT003 MDI

· Pearl Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PT003 MDI, covering 2017-01-31 to 2017-04-27. Get the full timeline:

Most recent: Clinical Trial Update: PT003 MDI Dose Confirmation Study [Phase 2]